{"title":"The Association of Smoking and SARS-CoV-2 Infection.","authors":"Hooman Sharifi, Atefeh Fakharian, Maryam Sadat Mirenayat, Gordafarid Moradian, Saba Karimzade, Pouria Tuyserkani, Reyhaneh Zahiri, Maryam Akhtari, Mahsa Rekabi, Nafiseh Nikpey, Hamidreza Jamaati","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>SARS-CoV-2 is a member of the coronavirus family that has caused infections in humans. Iran, as one of the countries in West Asia, is facing a high prevalence of this virus. In this study, we aimed to investigate the association between smoking and COVID-19 outcomes during the pandemic and sociodemographic characteristics.</p><p><strong>Materials and methods: </strong>This cross-sectional survey was done to assess the frequency of tobacco smoking in COVID-19 patients hospitalized at Masih Daneshvari Hospital, Tehran, Iran. All patients' basic and clinical characteristics, smoking status, and outcomes (ICU admission) were recorded.</p><p><strong>Results: </strong>A total of 254 participants, of whom 206 (81.10%) provided complete data on variables included in the present analyses. In the present study, 137 (66.5%) of all patients were men and 69 (33.5%) were women. Also, 63 (30.4%) of the study population had a family member with a current disease or history of COVID-19. Fourteen patients (6.79%) were ex-smokers and 34 (16.50%) were current smokers. We found significant relationships between Ex-smoking and ICU admission in COVID-19 patients.</p><p><strong>Conclusion: </strong>Ex-smoker inpatients with COVID-19 require special attention since they are a vulnerable population with a much higher morbidity rate.</p>","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":"23 1","pages":"83-89"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11655012/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tanaffos","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Background: SARS-CoV-2 is a member of the coronavirus family that has caused infections in humans. Iran, as one of the countries in West Asia, is facing a high prevalence of this virus. In this study, we aimed to investigate the association between smoking and COVID-19 outcomes during the pandemic and sociodemographic characteristics.
Materials and methods: This cross-sectional survey was done to assess the frequency of tobacco smoking in COVID-19 patients hospitalized at Masih Daneshvari Hospital, Tehran, Iran. All patients' basic and clinical characteristics, smoking status, and outcomes (ICU admission) were recorded.
Results: A total of 254 participants, of whom 206 (81.10%) provided complete data on variables included in the present analyses. In the present study, 137 (66.5%) of all patients were men and 69 (33.5%) were women. Also, 63 (30.4%) of the study population had a family member with a current disease or history of COVID-19. Fourteen patients (6.79%) were ex-smokers and 34 (16.50%) were current smokers. We found significant relationships between Ex-smoking and ICU admission in COVID-19 patients.
Conclusion: Ex-smoker inpatients with COVID-19 require special attention since they are a vulnerable population with a much higher morbidity rate.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
